A Study to Evaluate and Compare the Efficacy and Safety of Alectinib Versus Crizotinib and to Evaluate the Pharmacokinetics of Alectinib in Asian Participants With Treatment-Naive Anaplastic Lymphoma Kinase (ALK)-Positive Advanced Non-Small Cell Lung Cancer (NSCLC)

Rajavithi Hospital, Bangkok

Ramathibodi Hospital, Bangkok

Songklanagarind Hospital, Songkhla

Beijing Cancer Hospital, Beijing

Beijing Chest Hospital, Beijing

the First Hospital of Jilin University, Changchun

Jilin Cancer Hospital, Changchun

Harbin Medical University Cancer Hospital, Harbin

Shanghai chest hospital, Shanghai

Fudan University Shanghai Cancer Center, Shanghai

Shanghai Pulmonary Hospital, Shanghai

Jiangsu Cancer Hospital, Nanjing

The First Affiliated Hospital of College of Medicine, Zhejiang University, Hangzhou

Zhejiang Cancer Hospital, Hangzhou

Sun Yet-sen University Cancer Center, Guangzhou

Guangdong General Hospital, Guangzhou

The First Affiliated Hospital of Guangzhou Medical University, Guangzhou

West China Hospital, Sichuan University, Chengdu

Kangbuk Samsung Hospital, Seoul

Asan Medical Center, Seoul

Samsung Medical Center, Seoul